Mobiosense Company

Conventional troponin tests are not sensitive enough and require multiple tests over 12 hours to detect heart attack, and are not portable for use outside of the hospital. Mobiosense has developed HERO, a portable, high sensitivity troponin test that allows hospitals to rule in/out heart attack in just 3 hours, and allows for use in ambulances to begin the diagnostic protocol at the patient's side immediately, greatly reducing ER overcrowding and directing patients to the correct path of care.
Technology: Other
Industry: Health Care, Medical
Headquarters: Taiwan
Founded Date: 42736
Employees Number: 43840
Estimated Revenue: Less than $1M
Last Funding Date: 2017-11-01
Last Funding Type: Grant

Visit Website
contact@mobiosense.co
https://twitter.com/mobiosense?lang=en
Register and Claim Ownership